Oncology Pharma Inc. (ONPH)

Oncology Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Mar 31, 2013	Jun 30, 2011	Mar 31, 2004	Mar 31, 2003	Mar 31, 2002
Cash & Equivalents	0.01	-	0.01	1.35	2.93
Cash & Short-Term Investments	0.01	-	0.01	1.35	2.93
Cash Growth	-	-	-99.41%	-54.12%	-28.02%
Accounts Receivable	-	-	0.02	0.17	0.06
Receivables	-	0.02	0.02	0.17	0.06
Inventory	0.18	0.15	-	-	-
Other Current Assets	-	-	0.02	0.06	0.11
Total Current Assets	0.19	0.17	0.05	1.58	3.1
Property, Plant & Equipment	0.01	0.06	-	0.13	0.5
Other Intangible Assets	0.01	0.04	-	-	-
Other Long-Term Assets	-	-	-	0.05	0.01
Total Assets	0.2	0.26	0.05	1.75	3.61
Accounts Payable	0.01	0.01	0.01	0.27	0.17
Accrued Expenses	-	-	0.18	0.46	0.74
Short-Term Debt	0.21	0.66	0.03	-	-
Current Income Taxes Payable	0	-	-	-	-
Current Unearned Revenue	-	-	-	0.15	0.33
Total Current Liabilities	0.21	0.67	0.22	0.88	1.24
Long-Term Debt	0.21	-	-	-	-
Total Liabilities	0.42	0.67	0.22	0.88	1.24
Common Stock	0.41	0.07	0.01	0.01	0.01
Additional Paid-In Capital	25.4	25.38	25.38	24.87	24.76
Retained Earnings	-26.03	-25.86	-25.57	-24	-22.48
Comprehensive Income & Other	-	-	-	-	0.09
Total Common Equity	-0.22	-0.41	-0.17	0.87	2.37
Shareholders' Equity	-0.22	-0.4	-0.17	0.87	2.37
Total Liabilities & Equity	0.2	0.26	0.05	1.75	3.61
Total Debt	0.41	0.66	0.03	-	-
Net Cash (Debt)	-0.4	-0.66	-0.02	1.35	2.93
Net Cash Growth	-	-	-	-54.12%	-28.02%
Working Capital	-0.03	-0.5	-0.17	0.7	1.86
Tangible Book Value	-0.23	-0.44	-0.17	0.87	2.37
Buildings	-	-	-	0.04	0.04
Machinery	-	-	-	0.79	1.18
Leasehold Improvements	-	-	-	0.04	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.